Results 231 to 240 of about 2,039,180 (386)

Anomalous coronary arteries

open access: yesJournal of the American College of Cardiology, 1990
openaire   +2 more sources

Coronary arteries form by developmental reprogramming of venous cells

open access: yesNature, 2010
Kristy Red‐Horse   +3 more
semanticscholar   +1 more source

Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran   +2 more
wiley   +1 more source

The patient journey in chronic coronary syndromes with/without obstructive coronary arteries. [PDF]

open access: yesEur Heart J Qual Care Clin Outcomes
La S   +10 more
europepmc   +1 more source

Harnessing nanomaterials to precisely regulate the immunosuppressive tumor microenvironment for enhanced immunotherapy

open access: yesBMEMat, EarlyView.
The immunosuppressive tumor microenvironment, characterized by hypoxia, redox imbalance, elevated interstitial fluid pressure, and acidity, was comprehensively elucidated. This review discussed the etiology and consequences of the characteristics of the immunosuppressive tumor microenvironment, and analyzed the recent advancements in nanomaterials for ...
Wen Zhang   +7 more
wiley   +1 more source

Research advances in the etiology of in-stent restenosis of coronary arteries. [PDF]

open access: yesFront Cardiovasc Med
Bai H   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy